A person’s “bioenergetic age”-or how youthfully their cells generate energy-might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
Roche’s gene therapy biotech Spark is laying off employees, ending some early-stage programs
Roche’s Spark Therapeutics is letting staffers go and has “discontinued” several early-stage programs, a spokesperson confirmed to Endpoints News. “In May, Spark informed employees in